Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Lancet Neurology

• Publication date

  2004-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1474-4422(04)00825-7PMID 15261609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).

  2004cited by this paper
• Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement.

  2004cited by this paper
• Clinical manifestations of cerebral amyloid angiopathy–related inflammation

  2004cited by this paper
• Reversible leukoencephalopathy associated with cerebral amyloid angiopathy

  2004cited by this paper
• Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage

  2004cited by this paper
• Cerebral microbleeds are regionally associated with intracerebral hemorrhage

  2004cited by this paper
• Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View

  2003cited by this paper
• Amyloid β-Protein Stimulates the Expression of Urokinase-type Plasminogen Activator (uPA) and Its Receptor (uPAR) in Human Cerebrovascular Smooth Muscle Cells*

  2003cited by this paper
• Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages

  2003cited by this paper
• Thrombolysis for Ischemic Stroke in Patients with Old Microbleeds on Pretreatment MRI

  2003cited by this paper
• Cerebral hemorrhage produced by ruptured dissecting aneurysm in miliary aneurysm

  2003cited by this paper
• Pathogenic Aβ induces the expression and activation of matrix metalloproteinase‐2 in human cerebrovascular smooth muscle cells

  2003cited by this paper
• Matrix metalloproteinase–9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy

  2003cited by this paper
• APOE and cerebral amyloid angiopathy in the elderly

  2003cited by this paper
• Pathogenic A beta induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells.

  2003cited by this paper
• Prevalence of cerebral vascular amyloid-beta deposition and stroke in an aging Australian population: a postmortem study.

  2003cited by this paper
• Prevalence of cerebral vascular amyloid-β deposition and stroke in an aging Australian population : a postmortem study

  2003cited by this paper
• Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

  2003cited by this paper
• Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Abeta to physiologically relevant proteolytic degradation.

  2003cited by this paper
• Amyloid beta-protein stimulates the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells.

  2003cited by this paper
• Cerebral Microbleeds as a Risk Factor for Subsequent Intracerebral Hemorrhages Among Patients With Acute Ischemic Stroke

  2003cited by this paper
• Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke

  2003cited by this paper
• Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review.

  2003cited by this paper
• Cerebral amyloid angiopathy in aged Chinese: a clinico-neuropathological study

  2003cited by this paper
• Protective role of tuftsin fragment 1‐3 in an animal model of intracerebral hemorrhage

  2003cited by this paper
• Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria

  2003cited by this paper
• Plasma Metalloproteinase-9 Concentration Predicts Hemorrhagic Transformation in Acute Ischemic Stroke

  2003cited by this paper
• Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid β from the human brain

  2003cited by this paper
• Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke

  2002cited by this paper
• Cerebrovascular Disease Is a Major Factor in the Failure of Elimination of Aβ from the Aging Human Brain

  2002cited by this paper
• Compromised Hemodynamic Response in Amyloid Precursor Protein Transgenic Mice

  2002cited by this paper
• Thrombolysis induces cerebral hemorrhage in a mouse model of cerebral amyloid angiopathy

  2002cited by this paper
• Localization of a fibrillar amyloid beta-protein binding domain on its precursor.

  2002cited by this paper
• Abeta does not induce oxidative stress in human cerebrovascular smooth muscle cells.

  2002cited by this paper
• Silent Cerebral Microbleeds on T2*-Weighted MRI: Correlation with Stroke Subtype, Stroke Recurrence, and Leukoaraiosis

  2002cited by this paper
• Magnetic Resonance Imaging Detection of Microbleeds Before Thrombolysis: An Emerging Application

  2002cited by this paper
• Involvement of Matrix Metalloproteinase in Thrombolysis-Associated Hemorrhagic Transformation After Embolic Focal Ischemia in Rats

  2002cited by this paper
• Localization of a Fibrillar Amyloid β-Protein Binding Domain on Its Precursor*

  2002cited by this paper
• Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer's disease.

  2002cited by this paper
• Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy

  2001cited by this paper
• Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy

  2001cited by this paper
• Pathogenic Effects of D23N Iowa Mutant Amyloid β-Protein*

  2001cited by this paper
• Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke

  2001cited by this paper
• Analysis of Cerebral Amyloid Angiopathy in a Transgenic Mouse Model of Alzheimer Disease Using In Vivo Multiphoton Microscopy

  2001cited by this paper
• Apolipoprotein E genotype, coagulation, and survival following acute stroke

  2001cited by this paper
• Pathogenic effects of D23N Iowa mutant amyloid beta -protein.

  2001cited by this paper
• Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke

  2001cited by this paper
• Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria

  2001cited by this paper
• Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)–Induced Hemorrhage After Thromboembolic Stroke

  2000cited by this paper
• Amyloid‐β‐induced Degeneration of Human Brain Pericytes Is Dependent on the Apolipoprotein E Genotype

  2000cited by this paper
• Cerebral Amyloid Angiopathy in Alzheimer’s Disease and Related Disorders

  2000cited by this paper
• Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction.

  2000cited by this paper
• Fibrillar amyloid beta-protein binds protease nexin-2/amyloid beta-protein precursor: stimulation of its inhibition of coagulation factor XIa.

  2000cited by this paper
• Protease Nexin-2/Amyloid β-Protein Precursor Regulates Factor VIIa and the Factor VIIa–Tissue Factor Complex

  2000cited by this paper
• Warfarin-associated hemorrhage and cerebral amyloid angiopathy

  2000cited by this paper
• Mechanisms of Cerebrovascular Amyloid Deposition: Lessons from Mouse Models

  2000cited by this paper
• Fibrillar amyloid beta-protein binds protease nexin-2/amyloid beta-protein precursor: stimulation of its inhibition of coagulation factor XIa.

  2000cited by this paper
• APOE Genotype in Relation to Sporadic and Alzheimer-Related CAA

  2000cited by this paper
• CLINICAL NEUROSCIENCE: Amyloid beta-protein length and cerebral amyloid angiopathy-related haemorrhage

  2000cited by this paper
• Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage.

  2000cited by this paper
• Cerebrovascular Smooth Muscle Cell Surface Fibrillar Aβ: Alteration of the Proteolytic Environment in the Cerebral Vessel Wall

  2000cited by this paper
• Toxicity of various amyloid beta peptide species in cultured human blood-brain barrier endothelial cells: increased toxicity of dutch-type mutant.

  2000cited by this paper
• Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project.

  2000cited by this paper
• Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries.

  1999cited by this paper
• Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid.

  1999cited by this paper
• Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)

  1999cited by this paper
• Cerebral Amyloid Angiopathy–Related Hemorrhage Interaction of APOE ε2 With Putative Clinical Risk Factors

  1999cited by this paper
• MRI detection of new hemorrhages: Potential marker of progression in cerebral amyloid angiopathy

  1999cited by this paper
• MRI evidence of past cerebral microbleeds in a healthy elderly population

  1999cited by this paper
• Intracerebral haemorrhage and cerebral amyloid angiopathy: CT features with pathological correlation.

  1999cited by this paper
• Surgical intervention, biopsy and APOE genotype in cerebral amyloid angiopathy-related haemorrhage.

  1999cited by this paper
• The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage.

  1999cited by this paper
• Postoperative outcome of 37 patients with lobar intracerebral hemorrhage related to cerebral amyloid angiopathy.

  1999cited by this paper
• Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE epsilon2 with putative clinical risk factors.

  1999cited by this paper
• The Apolipoprotein E ∈2 Allele and the Pathological Features in Cerebral Amyloid Angiopathy-related Hemorrhage

  1999cited by this paper
• Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease.

  1998cited by this paper
• Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke

  1998cited by this paper
• Depressed platelet status in an elderly patient with hemorrhagic stroke after thrombolysis for acute myocardial infarction. GUSTO-III Investigators.

  1998cited by this paper
• Silent intracerebral microhemorrhages in patients with ischemic stroke

  1998cited by this paper
• Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy.

  1998cited by this paper
• Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

  1998cited by this paper
• Progression of Cerebral Amyloid Angiopathy: Accumulation of Amyloid-ß40 in Affected Vessels

  1998cited by this paper
• Risk for Intracranial Hemorrhage after Tissue Plasminogen Activator Treatment for Acute Myocardial Infarction

  1998cited by this paper
• Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy

  1998cited by this paper
• Cerebral amyloid angiopathy

  1998cited by this paper
• High frequency of apolipoprotein E ϵ2 Allele in hemorrhage due to cerebral amyloid angiopathy

  1997cited by this paper
• Neuroimaging of Vessel Amyloid in Alzheimer's Disease a, b

  1997cited by this paper
• Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.

  1997cited by this paper
• Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease

  1997cited by this paper
• Animal models of cerebral beta-amyloid angiopathy.

  1997cited by this paper
• Animal models of cerebral β-amyloid angiopathy

  1997cited by this paper
• Giant cell arteritis in association with cerebral amyloid angiopathy: immunohistochemical and molecular studies.

  1997cited by this paper
• Surgery for primary intracerebral hemorrhage: is it safe and effective? A systematic review of case series and randomized trials.

  1997cited by this paper
• Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

  1996cited by this paper
• β-Amyloid-mediated vasoactivity and vascular endothelial damage

  1996cited by this paper
• Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy

  1996cited by this paper
• Lack of an association between apolipoprotein E epsilon 4 and cerebral amyloid angiopathy in elderly Japanese.

  1996cited by this paper
• Lack of an association between apolipoprotein Eε4 and cerebral amyloid angiopathy in elderly japanese

  1996cited by this paper
• Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 22-1996. Cerebral hemorrhage in a 69-year-old woman receiving warfarin.

  1996cited by this paper
• Amyloid beta-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders.

  1996cited by this paper

• Fatal Outcome of Intravenous Thrombolysis With an Unexpected Finding of Amyloid‐β‐Related Angiitis—A Case Report Highlighting a Relevant Scenario With Acute Focal Neurological Deficits and Minimal Radiological Presentation

  2025cites this paper
• Histopathological study for dating of Subdural haemorrhage and Subarachnoid haemorrhage in a single cohort study of head injury.

  2025cites this paper
• Stroke caused by cerebral amyloid angiopathy: a case of difficult diagnosis

  2025cites this paper
• Clinical Research Progress on the Combined Use of Acupuncture and Medication in the Treatment of Cerebral Infarction

  2024cites this paper
• Machine learning detects hidden treatment response patterns only in the presence of comprehensive clinical phenotyping

  2024cites this paper
• Cilia‐Mimic Locomotion of Magnetic Colloidal Collectives Enhanced by Low‐Intensity Ultrasound for Thrombolytic Drug Penetration

  2024cites this paper
• Remote Intracerebral Haemorrhage Secondary to Vessel Rupture Following Bridging Intravenous Thrombolysis (Causal or Incidental) with Successful Endovascular Treatment: A Rare Case Report

  2024cites this paper
• Pre-treatment risk markers for hemorrhagic transformation in posterior circulation acute ischemic stroke treated with reperfusion therapy

  2023cites this paper
• Thrombolysis Outcomes in Acute Ischaemic Stroke Patients with Pre-Existing Cognitive Impairment

  2023influential citation
• Computed tomography pattern of severe cerebral amyloid angiopathy in the acute phase of stroke care: what should we do?

  2022cites this paper
• Models of cerebral amyloid angiopathy-related intracerebral hemorrhage

  2022cites this paper
• Fatal thrombolysis-related intracerebral haemorrhage associated with amyloid-β-related angiitis in a middle-aged patient – case report and literature review

  2022cites this paper
• Imaging of Cerebral Microbleeds: Primary Patterns and Differential Diagnosis

  2021cites this paper
• Charcot–Bouchard aneurysms revisited: clinicopathologic correlations

  2021cites this paper
• [Amyloid angiopathy brain hemorrhage].

  2021cites this paper
• Cognitive impairment in hypertension

  2021cites this paper
• Guiding Drug Through Interrupted Bloodstream for Potentiated Thrombolysis by C‐Shaped Magnetic Actuation System In Vivo

  2021cites this paper
• Spontaneous Splenic Artery Rupture as the First Symptom of Systemic Amyloidosis

  2021cites this paper
• Perihematomal Edema After Intracerebral Hemorrhage: An Update on Pathogenesis, Risk Factors, and Therapeutic Advances

  2021cites this paper
• Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke

  2020cites this paper
• Amyloid angiopathy as a cause of “intracranial remote haemorrhage” in a patient treated with fibrinolysis

  2019cites this paper
• Intracerebral Hemorrhage: A Brief Evidence-Based Review of Common Etiologies, Mechanisms of Secondary Injury, and Medical and Surgical Management

  2019cites this paper
• Atypical Clinical Manifestations of Cerebral Amyloid Angiopathy

  2019cites this paper
• Modulation of SPARC/Hevin Proteins in Alzheimer’s Disease Brain Injury

  2019cites this paper
• Cerebral Small Vessel Disease (CSVD) – Lessons From the Animal Models

  2019cites this paper
• Specific treatment of acute ischemic stroke

  2019cites this paper
• What caused this intracerebral hemorrhage?

  2019cites this paper
• The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer’s Disease-related Pathogenesis

  2019cites this paper
• The Risk of Symptomatic Intracranial Hemorrhage after Thrombolysis for Acute Stroke: Current Concepts and Perspectives

  2019cites this paper
• Amyloid angiopathy as a cause of "intracranial remote hemorrhage" in a patient treated with fibrinolysis.

  2019cites this paper
• Clinical Features and Prognosis of Primary Intraventricular Hemorrhage in Elderly: Single-Center Experience.

  2019cites this paper
• Intravenous thrombolysis for ischemic stroke in the Veneto region: the gap between eligibility and reality

  2018cites this paper
• Clinical Characteristics and Outcomes of Intracerebral Hemorrhage in Very Elderly.

  2018cites this paper
• Cerebral amyloid angiopathy: Review of clinico‐radiological features and mimics

  2018cites this paper
• Journal of Neuroscience and Neurological Surgery

  2018cites this paper
• Review: Vascular dementia: clinicopathologic and genetic considerations

  2018cites this paper
• Why not Intravenous Thrombolysis in Patients with Recurrent Stroke within 3 Months?

  2018cites this paper
• Cerebral Amyloid Angiopathy in Stroke Medicine.

  2017cites this paper
• Cerebral Amyloid Angiopathy

  2017cites this paper
• Management of acute ischaemic stroke in patients with dementia

  2017cites this paper
• Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia.

  2017cites this paper
• [Do cerebral microbleeds increase the risk of hemorrhagic complications of thrombolytic therapy?]

  2016cites this paper
• Intrazerebrale Blutung nach systemischer Lysetherapie

  2016cites this paper
• Secuencia T2 eco de gradiente versus secuencia ponderada de susceptibilidad angiológica en la detección de microhemorragias en pacientes hipertensos

  2016cites this paper
• Alzheimer disease is in part a thrombohemorrhagic disorder

  2016cites this paper
• [Do cerebral microbleeds increase the risk of hemorrhagic complications of thrombolytic therapy?]

  2016cites this paper
• Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results From a Multicenter Study

  2016cites this paper
• Cerebellar vermis: a vulnerable location of remote brain haemorrhages after thrombolysis for ischaemic stroke

  2016cites this paper
• Acute Convexity Subarachnoid Hemorrhage Related to Cerebral Amyloid Angiopathy: Clinicoradiological Features and Outcome.

  2016cites this paper
• Thrombolysis in dementia patients with acute stroke: is it justified?

  2016cites this paper
• Hypertension, Cognitive Decline, and Dementia

  2016cites this paper
• The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis.

  2016cites this paper
• Cerebral Microbleeds: Detection, Associations and Clinical Implications.

  2015cites this paper
• A Rapidly Progressive Dementia

  2015cites this paper
• Novel therapeutic and modeling approaches to experimental intracerebral hemorrhage

  2015cites this paper
• Cerebral Microbleeds and Thrombolysis-Associated Intracerebral Hemorrhage: Cause for Concern, or Just a Distraction?

  2015cites this paper
• Applied clinical neuroimaging in cerebral amyloid angiopathy and spontaneous intracerebral haemorrhage

  2015cites this paper
• Fatal intracerebral haemorrhage following intravenous thrombolysis for acute ischaemic stroke: A hidden role for cerebral amyloid angiopathy?

  2015cites this paper
• Cerebral Amyloid Angiopathy: Emerging Concepts

  2015cites this paper
• Safety of Percutaneous Ultrasound-Guided Kidney Biopsy in Patients with AA Amyloidosis

  2015cites this paper
• What causes intracerebral bleeding after thrombolysis for acute ischaemic stroke? Recent insights into mechanisms and potential biomarkers

  2015cites this paper
• Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk

  2015influential citation
• Thrombolysis-Related Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy: Accumulating Evidence

  2015cites this paper
• Cerebral amyloid angiopathy related hemorrhage after stroke thrombolysis: Case report and literature review

  2015cites this paper
• The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods

  2015cites this paper
• Zerebrale Amyloidangiopathie und Demenz

  2015cites this paper
• Blood-Brain Barrier Damage in the Context of HIV Infection and Drug Abuse

  2015cites this paper
• White Matter Changes in Dementia: Role of Impaired Drainage of Interstitial Fluid

  2015cites this paper
• Remote or Extraischemic Intracerebral Hemorrhage—An Uncommon Complication of Stroke Thrombolysis: Results From the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register

  2014cites this paper
• Cerebral Amyloid Angiopathy: A Hidden Risk for IV Thrombolysis?

  2014cites this paper
• Number of Cerebral Microbleeds and Risk of Intracerebral Hemorrhage After Intravenous Thrombolysis

  2014cites this paper
• Imaging spectrum of sporadic cerebral amyloid angiopathy: multifaceted features of a single pathological condition

  2014cites this paper
• Antithrombotic medications and the etiology of intracerebral hemorrhage

  2014cites this paper
• Prognostic Value of Plasma &bgr;-Amyloid Levels in Patients With Acute Intracerebral Hemorrhage

  2014cites this paper
• Special Edition on Cerebrovascular Disease

  2014influential citation
• Stroke-International Stroke Thrombolysis Register Stroke Thrombolysis : Results From the Safe Implementation of Treatments in An Uncommon Complication of − − Remote or Extraischemic Intracerebral Hemorrhage

  2014cites this paper
• Inflammatory amyloid angiopathy.

  2014cites this paper
• Inflammatory amyloid angiopathy.

  2014cites this paper
• Cerebral microbleeds as a marker of small vessel disease : new insights from neuro-imaging and clinical studies in stroke patients

  2014cites this paper
• Intracerebral hemorrhage in patients treated with intravenous thrombolysis for acute ischemic stroke

  2014cites this paper
• Small Vessel Disease and Memory Loss: What the Clinician Needs to Know to Preserve Patients’ Brain Health

  2013cites this paper
• Allergens are not pathogens

  2013cites this paper
• Ablation of astrocytic laminin impairs vascular smooth muscle cell function and leads to hemorrhagic stroke

  2013cites this paper
• Cerebral microbleeds: a guide to detection and clinical relevance in different disease settings

  2013cites this paper
• Brain Hemorrhages in Cerebral Amyloid Angiopathy

  2013cites this paper
• Microbleed Burden and Hematoma Expansion in Acute Intracerebral Hemorrhage

  2013cites this paper
• Prophylaxis and Treatment of Alzheimer's Disease by Delivery of an Adeno-Associated Virus Encoding a Monoclonal Antibody Targeting the Amyloid Beta Protein

  2013cites this paper
• Factors influencing haemorrhagic transformation in ischaemic stroke.

  2013cites this paper
• Immune complex formation impairs the elimination of solutes from the brain: implications for immunotherapy in Alzheimer’s disease

  2013cites this paper
• Molecular and clinical markers in ischaemic cerebrovascular disease

  2013cites this paper
• Do Cerebral Microbleeds Increase the Risk of Intracerebral Hemorrhage after Thrombolysis for Acute Ischemic Stroke?

  2013cites this paper
• Intracerebral Hemorrhage: Evidence-Based Medicine, Diagnosis, Treatment, and Complications

  2013cites this paper
• Postthrombolysis Intracranial Hemorrhage Risk of Cerebral Microbleeds in Acute Stroke Patients: A Systematic Review and Meta-Analysis

  2013cites this paper
• 脳梗塞に対するrt-PA静注療法後にcerebral microbleedsと同部位に脳出血を認めた1例

  2012cites this paper
• Predicting Cerebral Amyloid Angiopathy-Related Intracerebral Hemorrhages and Other Cerebrovascular Disorders in Alzheimer’s Disease

  2012cites this paper
• Cerebral Microbleeds on Magnetic Resonance Imaging and Anticoagulant-Associated Intracerebral Hemorrhage Risk

  2012cites this paper
• Plasma β-Amyloid Levels in Cerebral Amyloid Angiopathy-Associated Hemorrhagic Stroke

  2012cites this paper
• Inflammatory events at blood–brain barrier in neuroinflammatory and neurodegenerative disorders: Implications for clinical disease

  2012cites this paper
• Aging and the neurovascular unit

  2012cites this paper
• Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-analysis

  2012cites this paper